QIAGEN
Generated by Meeveem AI
"Provider of molecular diagnostics and Sample to Insight solutions for life sciences."
About QIAGEN
QIAGEN develops Sample to Insight technologies that turn biological samples into molecular information for research and clinical healthcare. More than 500,000 customers use its products, which include nucleic acid purification, digital PCR, next-generation sequencing and syndromic testing. Applications range from tuberculosis management to cancer diagnostics.
Founded in 1984, QIAGEN has its global headquarters in Venlo and a UK development and service site in Manchester. It reported about 5,400 employees across more than 35 locations in September 2026. Its 2025 portfolio comprised over 500 core products, including kits, instruments and bioinformatics. The group also has independently validated emissions targets and develops products intended to reduce laboratory environmental impact.
Learning and development
QIAGEN offers digital learning, expert-led training, language courses and mentoring across roles and career stages. Its Annual Performance and Development Cycle provides regular one-to-one discussions with managers about goals, training and longer-term career plans.
How the organisation works
The group brings together research and development, production, sales, marketing and administration. Its international facilities combine different functions: the Manchester operation covers development and service solutions, while other sites include manufacturing, distribution and bioinformatics.
5400
Team Members
1984
Founded
Diagnostics
Sector
Hybrid
Work Environment